During the past decade, Cardiac Study Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiac Study Center" #1 sponsor was "Actelion" with 1 trials, followed by "Biosense Webster, Inc." with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Mayo Clinic" with 1 trials sponsored and "University of California, San Francisco" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiac Study Center" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Zoll Medical Corporation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Cardiac Study Center" are "Atrial Fibrillation" (2 trials), "Arrhythmia" (1 trials), "Atherosclerosis" (1 trials), "Coronary Artery Disease" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Cardiac Study Center" in a lesser frequency.

Most popular intervention types in "Cardiac Study Center" are "Device" (4 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Catheter Ablation (NAVISTAR® THERMOCOOL® SF Catheter)" (1 trials), "Left atrial ablation" (1 trials), "Notapplicable" (1 trials), "Percutaneous coronary intervention (Promus PREMIER)" (1 trials) and "Ranolazine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiac Study Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Cardiac Study Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Cardiac Study Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiac Study Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".